 Triptorelin Pamoate
"Triptorelin Pamoate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE with D-tryptophan substitution at residue 6.
| Descriptor ID |
D017329
|
| MeSH Number(s) |
D06.472.699.327.740.320.790 D12.644.400.400.740.320.790 D12.644.456.460.800 D12.644.548.365.740.320.790 D12.776.631.650.405.740.320.790
|
| Concept/Terms |
Decapeptyl- Decapeptyl
- Decapeptyl Trimestral
- Trimestral, Decapeptyl
- Decapeptyl LP
- Decapeptyl Depot
Triptorelin- Triptorelin
- LHRH, Trp(6)-
- GnRH, Trp(6)-
- LHRH, Tryptophyl(6)-
- D-Trp-6-LH-RH
- 6-D-Tryptophan-Luteinizing Hormone-Releasing Factor (Pig)
Trelstar- Trelstar
- Triptorelin Embonate
- Embonate, Triptorelin
|
Below are MeSH descriptors whose meaning is more general than "Triptorelin Pamoate".
Below are MeSH descriptors whose meaning is more specific than "Triptorelin Pamoate".
This graph shows the total number of publications written about "Triptorelin Pamoate" by people in this website by year, and whether "Triptorelin Pamoate" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1997 | 0 | 1 | 1 | | 1998 | 1 | 0 | 1 | | 2001 | 0 | 1 | 1 | | 2002 | 1 | 0 | 1 | | 2003 | 1 | 0 | 1 | | 2004 | 3 | 0 | 3 | | 2006 | 0 | 1 | 1 | | 2008 | 1 | 0 | 1 | | 2009 | 1 | 2 | 3 | | 2012 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Triptorelin Pamoate" by people in Profiles.
-
Liu JH. What is new in reproductive endocrinology?: best articles from the past year. Obstet Gynecol. 2012 May; 119(5):1052-4.
-
Sundaram S, Trivedi R, Durairaj C, Ramesh R, Ambati BK, Kompella UB. Targeted drug and gene delivery systems for lung cancer therapy. Clin Cancer Res. 2009 Dec 01; 15(23):7299-308.
-
Sundaram S, Roy SK, Ambati BK, Kompella UB. Surface-functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium. FASEB J. 2009 Nov; 23(11):3752-65.
-
Sundaram S, Durairaj C, Kadam R, Kompella UB. Luteinizing hormone-releasing hormone receptor-targeted deslorelin-docetaxel conjugate enhances efficacy of docetaxel in prostate cancer therapy. Mol Cancer Ther. 2009 Jun; 8(6):1655-65.
-
Sundaram S, Roy SK, Kompella UB. Differential expression of LHRH-receptor in bovine nasal tissue and its role in deslorelin delivery. Peptides. 2009 Feb; 30(2):351-8.
-
Kompella UB, Sundaram S, Raghava S, Escobar ER. Luteinizing hormone-releasing hormone agonist and transferrin functionalizations enhance nanoparticle delivery in a novel bovine ex vivo eye model. Mol Vis. 2006 Oct 17; 12:1185-98.
-
Koushik KN, Kompella UB. Transport of deslorelin, an LHRH agonist, is vectorial and exhibits regional variation in excised bovine nasal tissue. J Pharm Pharmacol. 2004 Jul; 56(7):861-8.
-
Koushik K, Dhanda DS, Cheruvu NP, Kompella UB. Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes. Pharm Res. 2004 Jul; 21(7):1119-26.
-
Koushik K, Bandi N, Sundaram S, Kompella UB. Evidence for LHRH-receptor expression in human airway epithelial (Calu-3) cells and its role in the transport of an LHRH agonist. Pharm Res. 2004 Jun; 21(6):1034-46.
-
Koushik K, Sunkara G, Gwilt P, Kompella UB. Pathways and kinetics of deslorelin degradation in an airway epithelial cell line (Calu-1). Pharm Res. 2003 May; 20(5):779-87.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|